Background Luteinizing hormone (LH) and progesterone (PROG) on human chorionic
gonadotropin (hCG) trigger day are significantly correlated with assisted reproductive …

Purpose Gonadotrophin releasing hormone agonist (GnRH-a) is widely used for pituitary
down-regulation and recruiting more follicles in assisted reproduction. However, no …

Background Peak endometrial thickness (EMT), measured on the end of follicular phase or
early luteal phase, is the most widely used marker for endometrial receptivity during infertility …

In order to explore the impact of endometrial thickness on hCG administration day on
ongoing pregnancy rate (OPR) in IVF-ET cycles, we retrospectively analyzed data from …

Background The goal of this study was to assess the association between endometrial
thickness on the chorionic gonadotropin (hCG) day and in vitro fertilization and embryo …

Objective To investigate the factors that influence luteal phase short-acting gonadotropin-
releasing hormone agonist (GnRH-a) long protocol and GnRH-antagonist (GnRH-ant) …

Objective To compare the pregnancy outcome after fresh embryo transfer between GnRH
antagonist and GnRH agonist regimens in patients with thin endometrium. Methods This …

More than 3days' luteal endometrial advancement in IVF has been related with no
pregnancies. This study assessed the effect of recombinant and urinary human chorionic …

Introduction The optimal dosage of recombinant human luteinizing hormone (r-hLH) and its
impact on endometrial thickness (EMT) when administered alongside recombinant human …

Objective To investigate the effects of endometrial thickness (EMT) on pregnancy outcomes
on hCG trigger day in fresh in vitro fertilization (IVF) and intracytoplasmic sperm injection …